Skip to main content

Home
Browse by Topic
Issues
Special Series
- Conference Correspondent
  - ASH 2023 - CLL
- Ovarian Cancer Overview
Multimedia
Subscribe

Home
Browse by Topic
Issues
Special Series
- Conference Correspondent
  - ASH 2023 - CLL
- Ovarian Cancer Overview
Multimedia
Subscribe

Joanna Schwartz, PharmD, BCOP

Authored Items

New Developments in the Management of Hand-Foot Syndrome Associated With Oral Anti-VEGF Tyrosine Kinase Inhibitor–Targeted Anticancer Therapies

By Joanna Schwartz, PharmD, BCOP; Shannon Hogan, PharmD

TOP - May 2013, Vol 6, No 2

Supportive Care

Hand-foot skin reaction (HFSR), also known as hand-foot syndrome or palmar-plantar erythrodysesthesia (PPE), is an adverse effect of several chemotherapeutic agents. Read More ›

Back To Top

Home
About
Contact Us
Advertise
Subscribe

© Amplity Health. All Rights Reserved. Privacy Policy.

Get TOP in Your Inbox!

Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.

I have reviewed and consent to the terms of TOP Privacy Policy, and TOP has my permission to retain my information in its database, and to forward pertinent communications to me.